Outcomes and Need for Additional Interventions after Intravitreal Bevacizumab for Retinopathy of Prematurity
Ophthalmology Retina · 2025
DOI: 10.1016/j.oret.2024.11.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ophthalmology Retina, 2025. Verfasst von Ally J Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: UT Southwestern Medical Center, Dallas, Texas; Children's Medical Center Dallas, Dallas, Texas. Hauptthemen laut MEDLINE: Retinopathy of Prematurity, Bevacizumab, Laser Coagulation. Die Arbeit nennt 38 Literaturangaben. Gefördert von: Research to Prevent Blindness, National Institutes of Health, Foundation for the National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UT Southwestern Medical Center, Dallas, Texas; Children's Medical Center Dallas, Dallas, Texas.
- UT Southwestern Medical Center, Dallas, Texas; Children's Medical Center Dallas, Dallas, Texas. Electronic address: angeline.wang@utsouthwestern.edu.
Förderung
- Research to Prevent Blindness
- National Institutes of Health
- Foundation for the National Institutes of Health
Zitieren
APA
Sun, A. J., Garcia, B. Y., Patrick, H., He, Y. G., & Wang, A. L. (2025). Outcomes and Need for Additional Interventions after Intravitreal Bevacizumab for Retinopathy of Prematurity. Ophthalmology Retina. https://doi.org/10.1016/j.oret.2024.11.014
Vancouver
Sun AJ, Garcia BY, Patrick H, He YG, Wang AL. Outcomes and Need for Additional Interventions after Intravitreal Bevacizumab for Retinopathy of Prematurity. Ophthalmology Retina. 2025. doi:10.1016/j.oret.2024.11.014
BibTeX
@article{Sun2025,
author = {Sun, Ally J and Garcia, Brisa Y and Patrick, Hank and He, Yu-Guang and Wang, Angeline L},
title = {Outcomes and Need for Additional Interventions after Intravitreal Bevacizumab for Retinopathy of Prematurity},
journal = {Ophthalmology Retina},
year = {2025},
doi = {10.1016/j.oret.2024.11.014}
}
EUVIMED